Capital Impact Advisors, LLC Zynex Inc Transaction History

Capital Impact Advisors, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$9.86 - $13.74 $486,886 - $678,481	-49,380 Reduced 46.5%	56,818 $702,000
Q4 2023 Feb 14, 2024	BUY	$7.1 - $10.89 $381,944 - $585,827	53,795 Added 102.66%	106,198 $1.16 Million
Q2 2023 Aug 14, 2023	BUY	$8.59 - $14.56 $17,875 - $30,299	2,081 Added 4.14%	52,403 $502,000
Q1 2023 May 23, 2023	SELL	$9.53 - $16.8 $293,180 - $516,835	-30,764 Reduced 37.94%	50,322 $603,000
Q4 2022 Feb 14, 2023	SELL	$8.71 - $14.28 $237,783 - $389,844	-27,300 Reduced 25.19%	81,086 $1.13 Million
Q3 2022 Nov 21, 2022	BUY	$7.19 - $9.91 $21,368 - $29,452	2,972 Added 2.82%	108,386 $1.5 Million
Q2 2022 Aug 15, 2022	SELL	$5.78 - $8.87 $10,247 - $15,726	-1,773 Reduced 1.65%	105,414 $841,000
Q1 2022 May 16, 2022	BUY	$5.14 - $9.35 $550,941 - $1 Million	107,187 New	107,187 $668,000
Q4 2021 Feb 14, 2022	SELL	$8.71 - $13.77 $1.89 Million - $2.98 Million	-216,607 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$10.35 - $15.65 $440,206 - $665,625	-42,532 Reduced 16.41%	216,607 $2.47 Million
Q2 2021 Aug 17, 2021	BUY	$12.25 - $14.87 $394,646 - $479,051	32,216 Added 14.2%	259,139 $4.02 Million
Q1 2021 May 18, 2021	SELL	$12.28 - $19.74 $596,943 - $959,581	-48,611 Reduced 17.64%	226,923 $3.47 Million
Q4 2020 Feb 12, 2021	BUY	$11.65 - $17.94 $929,670 - $1.43 Million	79,800 Added 40.77%	275,534 $3.71 Million
Q3 2020 Nov 13, 2020	BUY	$12.98 - $25.98 $2.13 Million - $4.26 Million	164,000 Added 516.8%	195,734 $3.42 Million
Q2 2020 Aug 17, 2020	BUY	$9.06 - $23.49 $287,510 - $745,431	31,734 New	31,734 $789,000

103

8.4M

200

1.5K

Ticker ZYXI
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 37,453,400
Market Cap $308M
Description
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.